Michael W Deem - awarded Patent to combat diseases like HIV, Influenza, Dengue,
Certus llc was named winner of the United States Patent # US8398992 B2 - methods and compositions of polytopic vaccination beating out 100 other competitors to take home top honors.
United States Patent and Trademark Office presented the award to certus llc zoom. Details about the award can be found on the company website at https://image-ppubs.
Potential award recipients were required to submission on the USPTO website in order to be in contention for the United States Patent # US8398992 B2 - methods and compositions of polytopic vaccination, and were judged based on These patents were granted for multi-site vaccination against diseases There are four serotypes of dengue fever, and it has proven difficult to find a vaccine effective against all four serotypes.
Polytopic vaccination offers one approach to ameliorate this difficulty and offers a potential solution for an effective 4-component vaccine.
Other diseases with multiple subtypes to which this approach may lead to an effective vaccine include HIV, hepatitis B and C, chlamydia, and influenza. The polytopic vaccination approach was new, new, useful, and non-obvious, and My group invented the approach for infectious disease, building off our work on influenza vaccines.
It appears to significantly reduce immunodominance of multicomponent vaccines, and therefore significantly increase their effectiveness.
Michael W Deem, Founder of certus llc was pleased about the company's performance, saying: \"These patents were a milestone for vaccine design. Polytopic vaccination now allows us to design methods of administering multicomponent vaccines with high effectiveness.\" Michael W Deem, PhD\" Persons interested in learning more about certus llc and the award can visit the website at https://image-ppubs.
Find Out More about Michael W Deem At https://certusllc.com
Search
Read the Text Version
- 1 - 9
Pages:
